225 related articles for article (PubMed ID: 3005411)
21. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
Browning J; Ribolini A
J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
[TBL] [Abstract][Full Text] [Related]
22. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
Konur A; Schulz U; Eissner G; Andreesen R; Holler E
Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
24. Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding.
Buscema M; Todd I; Deuss U; Hammond L; Mirakian R; Pujol-Borrell R; Bottazzo GF
J Clin Endocrinol Metab; 1989 Aug; 69(2):433-9. PubMed ID: 2502555
[TBL] [Abstract][Full Text] [Related]
25. Short- and long-term synergistic effects of human tumor necrosis factor and interferon-gamma on A549 human lung cancer cells maintained in three-dimensional culture.
Beaupain R; Martyré MC
Anticancer Res; 1990; 10(4):1061-6. PubMed ID: 2116752
[TBL] [Abstract][Full Text] [Related]
26. The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor.
Nobuhara M; Kanamori T; Ashida Y; Ogino H; Horisawa Y; Nakayama K; Asami T; Iketani M; Noda K; Andoh S
Jpn J Cancer Res; 1987 Feb; 78(2):193-201. PubMed ID: 3030986
[TBL] [Abstract][Full Text] [Related]
27. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of carcinoembryonic antigen and biliary glycoprotein by gamma-interferon.
Takahashi H; Okai Y; Paxton RJ; Hefta LJ; Shively JE
Cancer Res; 1993 Apr; 53(7):1612-9. PubMed ID: 8453631
[TBL] [Abstract][Full Text] [Related]
29. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
30. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.
Ding AH; Nathan CF
J Immunol; 1987 Sep; 139(6):1971-7. PubMed ID: 3040860
[TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia.
Buck C; Digel W; Schöniger W; Stefanic M; Ragnavachar A; Heimpel H; Porzsolt F
Leukemia; 1990 Jun; 4(6):431-4. PubMed ID: 2162999
[TBL] [Abstract][Full Text] [Related]
32. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
Nedwin GE; Svedersky LP; Bringman TS; Palladino MA; Goeddel DV
J Immunol; 1985 Oct; 135(4):2492-7. PubMed ID: 3928750
[TBL] [Abstract][Full Text] [Related]
33. Augmented procoagulant activity in cancer patients, treated with recombinant interferon-gamma in addition to recombinant tumor necrosis factor-alpha and melphalan.
Mulder AB; Zwaveling JH; Smid WM; Maring JK; van Ginkel RJ; Girbes AR; Schraffordt Koops H; van der Meer J
Thromb Haemost; 1996 Dec; 76(6):897-901. PubMed ID: 8972008
[TBL] [Abstract][Full Text] [Related]
34. Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis.
Benedetto N; Folgore A; Galdiero M; Meli R; Di Carlo R
Pathol Biol (Paris); 1995 May; 43(5):395-400. PubMed ID: 8532376
[TBL] [Abstract][Full Text] [Related]
35. Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines.
Beran M; Andersson BS; Kelleher P; Whalen K; McCredie K; Gutterman J
Blood; 1987 Mar; 69(3):721-6. PubMed ID: 3028534
[TBL] [Abstract][Full Text] [Related]
36. Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay.
Saito T; Berens ME; Welander CE
Cancer Res; 1986 Mar; 46(3):1142-7. PubMed ID: 3080233
[TBL] [Abstract][Full Text] [Related]
37. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line.
Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC
J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105
[TBL] [Abstract][Full Text] [Related]
38. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
39. Effects of alpha, beta and gamma recombinant interferons on CEA production from HT-29 human colon adenocarcinoma cell line.
Bombardieri E; Cocciolo MG; Valtolina M; Giussani C; Ringhini R; Esposito G; Buraggi GL
J Biol Regul Homeost Agents; 1987; 1(3):133-42. PubMed ID: 3140598
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
